5 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 10 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Bumetanide: new trials by email Literature Review of Bumetanide trials Research Report on Bumetanide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models Bumetanide, Treatment as usual (TAU) - Autism Spectrum Disorder | Phase 2 | Completed | Fei Li | 66 | 2025-06-04 | 2026-04-29 |
| A Study of Ultra High Dose Diuretics to Treat Heart Failure Bumetanide, Furosemide - Heart Failure; With Decompensation | Phase 2 | Completed | Mayo Clinic | 20 | 2023-11-27 | 2026-01-14 |
| Bumetanide in Patients With Alzheimer's Disease Bumetanide, Placebo - Alzheimer Disease | Phase 2 | Recruiting | Stanford University | 40 | 2023-04-10 | 2026-01-14 |
| Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome Bumetanide, Placebo - Down Syndrome | Phase 2 | Unknown | Stefano Vicari | 64 | 2023-01-11 | 2024-06-20 |
| Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial Chlorthalidone, Bumetanide - Renal Insufficiency, Chronic | Phase 2 | Completed | Hospital General de México Dr. Eduardo Liceaga | 34 | 2019-06-18 | 2020-11-23 |
| A Study of Bumetanide for the Treatment of Autism Spectrum Disorders Bumetanide, Placebo - Autism Spectrum Disorder | Phase 2 | Completed | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 120 | 2017-05-24 | 2021-03-01 |
| Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells Hepatic artery embolization (HAE), Bumetanide - Unresectable Hepatocellular Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 30 | 2017-04-05 | 2026-05-05 |
| Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology Bumetanide, Placebo - Autistic Disorder | Phase 2 | Withdrawn | University Hospital, Limoges | 2016-12-01 | 2026-06-09 | |
| Bumetanide in Hypokalaemic Periodic Paralysis Bumetanide, Placebo - Hypokalemic Periodic Paralysis | Phase 2 | Terminated | University College, London | 12 | 2015-01-01 | 2018-02-07 |
| NEMO1:NEonatal Seizure Using Medication Off-patent Bumetanide - Neonatal Seizures | Phase 1 / Phase 2 | Completed | Great Ormond Street Hospital for Children NHS Foundation Trust | 14 | 2011-08-01 | 2015-09-14 |
Autism Spectrum Disorder (2) · Alzheimer Disease (1) · Autistic Disorder (1) · Down Syndrome (1) · Edema (1) · Heart Failure (1) · Hypokalemic Periodic Paralysis (1) · Hypoxia-Ischemia, Brain (1) · Renal Insufficiency, Chronic (1)
Fei Li (1) · Great Ormond Street Hospital for Children NHS Foundation Trust (1) · Hospital General de México Dr. Eduardo Liceaga (1) · Mayo Clinic (1) · Memorial Sloan Kettering Cancer Center (1) · Stanford University (1) · Stefano Vicari (1) · University College, London (1) · University Hospital, Limoges (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (3) · China (2) · United Kingdom (2) · France (1) · Ireland (1) · Italy (1) · Mexico (1) · Netherlands (1) · Sweden (1)
Doreen Fialho, MD, PhD (1) · Fabio Solis-Jimenez, M.D. (1) · Fei Li, doctor (1) · Hooman Yarmohammadi, MD (1) · Kyan Younes, MD (1) · Ronit Pressler, Dr (1) · Stefano Vicari (1) · Yogesh Reddy, M.B.B.S (1)